Mark Christopher Capone, President & C.E.O at MYRIAD GENETICS INC (MYGN), sold 80,000 shares at $41.00 ($3.3M) on 2018-07-11, disclosed to the SEC on 2018-07-13.
Open-market sale of $3.3M MYGN by President & C.E.O. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.00 | 2,346 | $96K | 2.9% |
| 2 | $41.00 | 77,654 | $3.2M | 97.1% |
| Total | $41.00 avg | 80,000 | $3.3M | 100% |
| Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |
| MYGN | SELL | 2014-02-25 | $3.6M | — | Filing → |